TCM-1: A nonlinear dynamical computational model to simulate cellular changes in the T cell system; conceptional design and validation

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 123-135

  Krueger, Gerhard R F ^a   Brandt, Michael E ^b   Wang, Guanyu ^b   Maximilian Buja, L ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b University of Texas School of Health Information Sciences at Houston   (United States)

Author keywords

Cellular changes; Computational model; T cell system

Indexed keywords

CHEMOKINE; CYTOKINE;

APLASIA; ARTICLE; CALCULATION; CANALE SMITH SYNDROME; CARCINOGENESIS; COMPUTER AIDED DESIGN; COMPUTER MODEL; COMPUTER SIMULATION; DISEASE CLASSIFICATION; HELPER CELL; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS; HYPERPLASIA; LYMPHOPROLIFERATIVE DISEASE; NEOPLASM; PRIORITY JOURNAL; REGULATORY MECHANISM; SYNDROME; T LYMPHOCYTE; VALIDATION PROCESS; VIRUS INFECTION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL DIVISION; COMPUTER SIMULATION; HERPESVIRUS 6, HUMAN; HIV INFECTIONS; HIV-1; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MODELS, IMMUNOLOGICAL; NONLINEAR DYNAMICS; ROSEOLOVIRUS INFECTIONS; T-LYMPHOCYTES, HELPER-INDUCER; VIRUS DISEASES;

EID: 0037231312     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Krueger GRF, Malmgren RA and Berard CW: Malignant lymphomas and plasmacytosis in mice under chronic immunosuppression and persistent antigenic stimulation. Transplantation 11: 128-144, 1971.
2. Krueger GRF: Chronic immunosuppression and lymphomagenesis in man and mice. Natl Cancer Inst Monogr 35: 183-190, 1972.
3. Krueger G, Fischer RM and Flesch HG: Sequential changes in T - and B - cells, virus antigen expression and primary histologic diagnosis in virus - induced lymphomagenesis in mice. Z Krebsforsch 92: 41-54, 1979.
4. Kraus M and Krueger GRF: T - and B - cell determination in various lymphoid tissues of mice during N - nitrosobutylurea (NBU) leukemogenesis. J Cancer Res Clin Oncol 100: 149-165, 1981.
5. Heine UI, Krueger GRF, Karpinski A, Munoz E and Krueger MB: Quantitative light and electron microscopic changes in thymic reticular epithelial cells during Moloney virus - induced lymphoma development. J Cancer Res Clin Oncol 106: 102-111, 1983.
6. Krueger GRF, Karpinski A, Heine UI and Koch B: Differentiation block of prethymic lymphocytes during Moloneyvirus - induced lymphoma development associated with a thymic epitheliel defect. J Cancer Res Clin Oncol 106: 153-157, 1983.
7. Krueger GRF, Stolzenburg T and Muller C: Cell membrane lipid fluidity and receptor expression in Moloney - and Friendvirus transformed cells. In Vivo 1: 343-246, 1987.
8. Daefler S and Krueger GRF: Expression of proliferation and differentiation antigens in response to modulation of membrane lipid fluidity in chronic lymphatic leukemia lymphocytes. Anticancer Res 9: 501-506, 1989.
9. Daefler S and Krueger GRF: Lack of dynamic lipid changes after binding of interleukin-2 in chronic lymphocytis leukemia lymphocytes indicates defective transmembrane signaling. Anticancer Res 9: 743-748, 1989.
10. Purtilo DT, Tatsumi E, Manolov G, Manolova Y, Harada S, Lipscomb H and Krueger GRF: Epstein - Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients. Int Rev Exp Path 27: 113-183, 1985.
11. Krueger GRF and Ferrer Argote V: A unifying concept of viral immunopathogeneis of proliferative and aproliferative diseases (working hypothesis). In Vivo 8: 493-500, 1994.
12. Schonnebeck M, Krueger GRF, Braun M, Fischer M, Koch B, Ablashi DV and Balachandran N: Human herpesvirus-6 infection may predispose cells for superinfection by other viruses. In Vivo 5: 255-264, 1991.
13. Feaux de Lacroix W, Deying T and Krueger GRF: Cell proliferation in the T lymphocyte - lineage during the latent period of Moloney virus induced lymphomagenesis. XIth. ESGCP Meeting, Aarhus, Denmark, May 12-15, 1981 (book of abstracts).
14. Haas W, Deying T, Krueger GRF and Feaux de Lacroix W: Autoradiographic and immunocytologic identification of atypical cell proliferation during Moloneyvirus induced lymphoma development. Adv Compar Leukemia Res pp. 24-243, 1982.
15. Heine UI, Krueger GRF, Munoz E and Karpinski A: Altered thymic epithelial cells may be decisive for Moloneyvirus - induced lymphoma development. Proc. 41st. Ann Meeting EM Soc of America, p. 784-785, 1983 (G.W.Bailey, ed.).
16. Krueger GRF, Ablashi DV, Salahuddin SZ and Josephs SF: Diagnosis and differential diagnosis of progressive lymphoproliferation and malignant lymphoma in persistent active herpesvirus infection. J Virol Methods 21: 255-264, 1988.
17. Krueger GRF: The pathology of diphenylhydantoin - induced lymphoproliferative reactions in animals. In: Kammueller ME, Blocksma N, Deinen W: Autoimmunity and Toxicology. Elsevier, Amsterdam 391-413, 1989.
18. Krueger GRF, Papadakis T and Schaefer HJ: Persistent active Epstein - Barr virus infection and atypical lymphoproliferation. Am J Surg Pathol 11: 972-981, 1987.
19. Krueger GRF: Pathology of lymphoproliferative disorders in HIV infection. In: Schrappe M, Mauff G: AIDS - SIDA, a Comparison between Europe and Africa. Ed Roche, Basel 239-253, 1993.
20. Krueger GRF, Nguyen AND, Uthman M, Brandt ME and Buja LM: Dysregulative lymphoma theory revisited: what can we learn from cytokines, CD classes and genes? Anticancer Res 21: 3653-3662, 2001.
21. Krueger GRF: Abnormal variation of the immune system as related to cancer. In: Kaiser HE: Cancer Growth and Progression. Kluwer Acad Publ, Dordrecht NL, 139-161, 1989.
22. Brandt ME, Wang G, Krueger GRF and Buja LM: A biodynamical regulatory model of the human T cell system. Proceedings of the Second Meeting of the IEEE Engineering in Medicine and Biology Society and the Biomedical Engineering Society, Houston, Texas. Eng Med Biol, Oct 2002, abstract.
23. Brandt ME, Krueger GRF, Wang G and Buja LM: A biodynamical model of human T cell development and pathology: Conceptional design and validation. Submitted for publication 2002.
24. Liu CP and Auerbach R: Ontogeny of murine T cells: thymus - regulated development of T cell receptor - bearing cells derived from embryonal yolk sac. Eur J Immunol 21: 1849-1855, 1991.
25. Eren R, Zharhary D, Abel L and Globerson A: Ontogeny of T cells: development of pe - T cells from fetalliver and yolk sac in the thymus microenvironment. Cell Immunol 108: 76-84, 1987.
26. Correla - Neves M, Mathis D and Benoist C: A molecular chart of thymocyte positive selection. Eur J Immunol 31: 2583-2592, 2001.
27. Sen J: Signal transduction in thymus development. Cell Mol Biol 47: 197-215, 2001.
28. Chen CH, Six A, Kubota T, Tsuji S, Kong FK, Gobel TW and Cooper MD: T cell - receptors and T cell development. Curr Top Microbiol Immunol 212: 37-53, 1996.
29. Janossy G, Campana D and Akbar A: Kinetics of T cell development. Curr Top Pathol 79: 59-99, 1989.
30. Leclercq G and Plum J: Thymic and extrathymic T cell development. Leukemia 10: 1853-1859, 1996.
31. Pawelec G, Muller R, Rehbein A, Hahnel K and Ziegler BL: Extrathymic T cell differentiation in vitro from human CD34+ stem cells. J Leucoc Biol 64: 733-739, 1998.
32. Suzuki K, Oida T, Hamada H, Hitotsumatsu O, Watanaba M, Hibi T, Yamamoto H, Kubota E, Kaminogawa S and Ishikawa H: Gut cryptopatches: direct evidence of extrathymic anatomical sites for intestinal T lymphopoiesis. Immunity 13: 691-702, 2000.
33. Montecino - Rogriguez E, Truong LT and Henderson AJ: Long-term bone marrow cultures provide access to early lymphoid progenitors. J Hematother Stem Cell Res 10: 107-114, 2001.
34. Stutman O: Intrathymic and extrathymic T -cell maturation. Immunol Rev 42: 138-184, 1978.
35. Atkins B, Mueller C, Okada CY, Reinert RA, Weissman IL and Spangrude GJ: Early events in T-cell maturation. Ann Rev Immunol 5: 325-365, 1987.
36. Lobach DF and Haynes BF: Ontogeny of the human thymus during fetal development. J Clin Immunol 7: 81-97, 1987.
37. Dappen GE, Crouse DA, Anderson RW, Jordan RK, Robinson JH and Sharp JG: Morphological assessment of immunologically relevant cells in the thymus. Adv Exp Biol Med 149: 389-399, 1982.
38. Surh CD and Sprent J: The thymus and T - cell development. Chapter 9 In: Gallin JI et al: Inflammation: Basic Principles and Clinical Correlates. Lippincott Williams & Wilkins, Philadelphia 137-149, 1999.
39. Crouse DA, Jordan RK and Sharp JG: T -cell differentiation. In: Battisto & Knight eds.: Immunoglobulin Genes and Cell Differentiation. Elsevier - North Holland, Amsterdam NL 1980: 65-78.
40. Rothenberg E and Lugo JP: Differentiation and cell division in the mammalian thymus. Developmental Biol 112: 1-17, 1985.
41. Allison JP: Structure, function and serology of the T -cell antigen complex. Ann Rev Immunol 5: 503-540, 1987.
42. Miescher C, Howe RC, Budd RC and MacDonald HR: Expression of T -cell receptors by functionally distinct subsets of immature adult thymocytes. Ann NYAS 532: 8-17, 1988.
43. Kronenberg M, Siu G, Hood LE and Shastri N: The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Ann Rev Immunol 4: 529-591, 1986.
44. Dardenne M, Pleau JM, Man NK and Bach JF: Structure of circulating thymic factor: a peptide isolated from pig serum. I. Isolation and purification. J Biol Chem 252: 8040-8044, 1977.
45. Goldstein G: Molecular control of proliferation and differentiation. NYAS 249: 177-185, 1977.
46. Crouse DA, Turpen JB and Sharp JG: Thymic non - lymphoid cells. Surv Immunol Res 4: 120-134, 1985.
47. de la Hera A, Marston W, Aranda C, Toribio ML and Martinez C: Thymic stroma is required for the development of human T celllineages in vitro. Int Immunol 1: 471-478, 1989.
48. + thymocyte maturation: pre-T and NK cell differentiation on neonatal thymic stromal cell culture. Cell Immunol 190: 23-32, 1998.
49. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Molecular biological ontogenesis of the thymic reticulo - epithelial cell network during the organization of the cellular microenvironment. In Vivo 13: 267-294, 1999.
50. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: The role Of the reticulo - epithelial (RE) cell network in the immuno-neuroendocrine regulation on intrathymic lymphopoiesis. Anticancer Res 20: 1871-1888, 2000.
51. + hemopoietic cells. Leukemia & Lymphoma 24: 11-25, 1996.
52. Marrack P, Lo D, Brinster R et al.: The effect of thymus environment on T cell development and tolerance. Cell 53: 627-634, 1988.
53. Peled A, Petit I, Kollet O et al.: Dependence of human stem cell engraftment and repopulation mice on CXCR. Science 283: 845-848, 1999.
54. Petri HT, Livak F, Burtrum D and Mazel ST: T cell receptor gene recombination patterns and mechanisms: cell death, rescue, and T cell production. J Exp Med 182: 121-127, 1995.
55. Davis MH and Chien YH: T-cell antigen receptors. In: Paul WE: Fundamental Immunology, 4th edition. Lippincott-Raven, Philadelphia 1999, 341-366.
56. Korsmeyer J: Immunoglobulin and T-cell receptor genes reveal the clonality, lineage and translocations of lymphoid neoplasms. In: De Vita VT, Hellman S, Rosenberg: Important Advances in Oncology. Lippincott, Philadelphia 1987: 3-25.
57. Krueger GRF, Marshall GR, Junker U, Schroeder HJ, Buja LM and Wang G: Growth factors, cytokines, chemokines and neuropeptides in the modelling of T cells. In Vivo 16: 365-386, 2002.
58. Krueger GRF: Klinische Immunpathologie. W. Kohlhammer VerlagJ Stuttgart 1985.
59. Ogawa T, Kitagawa M and Hirokawa K: Age - related changes of human bone marrow: a histometric estimation of proliferative cells, apoptotic cells, T cells, B cells and macrophages. Mechanisms Ageing Develop 117: 57-68, 2000.
60. Krueger GRF, Bertram G, Ramon A, Koch B, Ablashi DV, Brandt ME, Wang G and Buja LM: Dynamics of infection with human herpesvirus-6 in EBV-negative infectious mononucleosis: data acquisition for computer modelling. In Vivo 15: 373-380, 2001.
61. Krueger GRF, Koch B, Hoffmann A, Rojo J, Brindt ME, Wang G and Buja LM: Dynamics of chronic active herpesvirus - 6 infection in patients with chronic fatigue syndrome: data acquisition for computer modelling. In Vivo 15: 461-466, 2001.
62. Krueger GRF, Koch B, Denninger J, Tymister G, Ramon A, Brandt ME, Wang G and Buja ME: Dynamics of active progressive infection with HIV 1: data acquisition for computer modelling. In Vivo 15: 513-518, 2001.
63. Krueger GRF, Brandt ME, Wang G and Buja LM: Dynamics of HTLV-1 leukemogenesis: data acquisition for computer modelling. In Vivo 16: 87-92, 2002.
64. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA and Lusso P: CD46 is a cellular receptor for human herpesvirus - 6. Cell 23: 817-827, 1999.
65. Mims CA: Immunobiology and pathogenesis of persistent virus infections. In: Lopez C: Immunobiology and Pathogenesis of Persistent Virus Infections. Amer Soc Microbiol, Washington DC 1988, 3-17.
66. Krueger GRF, Ablashi DV and Gallo RC (eds): Persistent herpesvirus infections. J Virol Methods 21: 1-326, 1988.
67. Straus SE: Chronic Epstein - Barr virus infection: a critical assessment. In: Lopez C: Immunobiology and Pathogenesis of Persistent Virus Infections. Amer Soc Microbiol, Washington DC 1988, 281-293.
68. Copeland KF, Haaksma AG, Goudsmit J, Krammer PH and Hooney JL: Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res Hum Retroviruses 10: 1259-1268, 1994.
69. Brauweiler A, Garrus JE, Reed JC and Nyborg JK: Repression of box gene expression by HTLV-1 Tax protain: implications for suppression of apoptosis in virally infected cells. Virology 28: 135-140, 1997.
70. Bar-Or RL and Segel LA: On the role of a possible dialogue between cytokine and TCR presentation mechanisms in the regulation of autoimmune disease. J theor Biol 190: 161-178, 1998.
71. Segel LA and Bar-Or RL: On the role of feedback in promoting conflicting goals of the adaptive immune system. J Immunol 163: 1342-1349, 1999.
72. Bar-Or RL: Feedback mechanisms between T helper cells and macrophages in the determination of the immune response. Mathematical Biosciences 163: 35-58, 2000.
73. Kam N, Cohen IR and Harel D: The immune system as a reactive system: modeling T cell activation with statecharts. Proc Symposia Human-Centric Computing Languages and Environments, pp. 15-22, Stresa Italy 2001, IEEE Computer Society Press.
74. Forrest S and Hofmeyr SA: Immunology as information processing. In: Segel LA, Cohen IR: Design Principles for Immune System & other Distributed Autonomous Systems. Oxford Univ Press 2000, pp. 361-387.
75. Warrender C, Forrest S and Segel L: Effective feedback in the immune system. In: Morgan & Kaufmann: Genetic and Evolutionary Computation Conference Workshop Program, 2001, pp. 329-332.
76. Smith DJ, Forrest S, Ackley DH and Perelson AS: Using lazy evaluation to simulate realistic-size repertoires in models of the immune system. Bull Mathematical Biology, in press (2002).
77. Krueger GRF, Brandt ME, Wang G, Berthold F and Buja LM: A computational analysis of Canale-Smith syndrome: chronic lymphadenopathy simulating malignant lymphoma. Anticancer Res 22: 2365-2372, 2002.
78. Germain RN: The art of the probable: system control in the adaptive immune system. Science 293: 240-245, 2001.
79. Hoyne GF, Dallman MJ, Champion BR and Lamb JR: Notch signaling in the regulation of peripheral immunity. Immunol Rev 182: 215-227, 2001.